Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approach

被引:26
|
作者
Burt, F. J. [1 ,2 ]
Samudzi, R. R. [1 ]
Randall, C. [1 ]
Pieters, D. [1 ]
Vermeulen, J. [1 ]
Knox, C. M. [3 ]
机构
[1] Univ Orange Free State, Fac Hlth Sci, Dept Med Microbiol & Virol, ZA-9300 Bloemfontein, South Africa
[2] Universitas, Natl Hlth Lab Serv, ZA-9300 Bloemfontein, South Africa
[3] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, South Africa
关键词
Crimean-Congo hemorrhagic fever virus; Antigenicity; Nucleoprotein; PEPTIDES; EXPRESSION; EPITOPES;
D O I
10.1016/j.jviromet.2013.07.055
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne viral zoonosis widely distributed in Africa, Asia and eastern Europe. In this study, amino acid sequence data for the CCHFV nucleoprotein (NP) was used to identify potential linear epitopic regions which were subsequently included in the design of large and small truncated recombinant NP antigens and peptide libraries. Two truncated recombinant CCHFV NP antigens were prepared based on results of prediction studies to include epitopic regions and exclude hydrophobic regions that could influence protein expression and solubility. Serum samples were collected from acute and convalescent patients. An IgG antibody response was detected in 16/16 samples tested using the large recombinant NP-based ELISA and in 2/16 using the small recombinant NP-based ELISA. A total of 60 peptides covering predicted epitopic regions of the NP were synthesized and peptide NRGGDENPRGPVSR at amino acid position 182-195, reacted with 13/16 human serum samples. In summary, functional assays are required to determine the biological activity of predicted epitopes for development of peptide based assays for antibody detection. Bacterially expressed complete NP antigens have previously been shown to be useful tools for antibody detection. Truncation of the antigen to remove the hydrophobic C terminus had no impact on the ability of the antigen to detect IgG antibody in human sera. The results indicate that the region from amino acids 123 to 396 includes a highly antigenic region of the NP with application in development of antibody detection assays. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:706 / 712
页数:7
相关论文
共 50 条
  • [21] A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus
    Hirano, Minato
    Sakurai, Yasuteru
    Urata, Shuzo
    Kurosaki, Yohei
    Yasuda, Jiro
    Yoshii, Kentaro
    ANTIVIRAL RESEARCH, 2022, 200
  • [22] CASES OF CRIMEAN-CONGO HEMORRHAGIC-FEVER IN ASTRAKHAN REGION
    SMIRNOVA, SE
    SEDOVA, AG
    ZIMINA, YV
    KARAVANOV, AS
    VOPROSY VIRUSOLOGII, 1990, 35 (03) : 228 - 231
  • [23] The first Crimean-Congo hemorrhagic fever cases in our region
    Kaya, Onur
    Akcam, Fusun Zeynep
    Nurlu-Temel, Esra
    Yayli, Guler
    KLIMIK JOURNAL, 2008, 21 (01) : 24 - 27
  • [24] A Crimean-Congo Hemorrhagic Fever Case in an Endemic Region in November
    Tavsan, Oznur
    Duygu, Fazilet
    Kaya, Turan
    KLIMIK JOURNAL, 2012, 25 (03) : 130 - 132
  • [25] Crimean-Congo Hemorrhagic Fever Virus: Strategies to Combat with an Emerging Threat to Human
    Pratap, Shivendra
    Narwal, Manju
    Dev, Aditya
    Dhindwal, Sonali
    Tomar, Shailly
    Kumar, Pravindra
    CURRENT BIOINFORMATICS, 2012, 7 (04) : 467 - 477
  • [26] Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus
    Andersson, I
    Bladh, L
    Mousavi-Jazi, M
    Magnusson, KE
    Lundkvist, Å
    Haller, O
    Mirazimi, A
    JOURNAL OF VIROLOGY, 2004, 78 (08) : 4323 - 4329
  • [27] Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
    Leventhal, Shanna S.
    Bisom, Thomas
    Clift, Dean
    Rao, Deepashri
    Meade-White, Kimberly
    Shaia, Carl
    Murray, Justin
    Mihalakakos, Evan A.
    Hinkley, Troy
    Reynolds, Steven J.
    Best, Sonja M.
    Erasmus, Jesse H.
    James, Leo C.
    Feldmann, Heinz
    Hawman, David W.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [28] Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein
    Tipih, Thomas
    Heise, Mark
    Burt, Felicity Jane
    VACCINES, 2021, 9 (12)
  • [29] LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
    Xu, Zhi-Sheng
    Du, Wen-Tian
    Wang, Su-Yun
    Wang, Mo-Yu
    Yang, Yi-Ning
    Li, Yu-Hui
    Li, Zhen-Qi
    Zhao, Li-Xin
    Yang, Yan
    Luo, Wei-Wei
    Wang, Yan-Yi
    CELL RESEARCH, 2024, 34 (02) : 140 - 150
  • [30] Unique Strain of Crimean-Congo Hemorrhagic Fever Virus, Mali
    Zivcec, Marko
    Maiga, Ousmane
    Kelly, Ashley
    Feldmann, Friederike
    Sogoba, Nafomon
    Schwan, Tom G.
    Feldmann, Heinz
    Safronetz, David
    EMERGING INFECTIOUS DISEASES, 2014, 20 (05) : 911 - 913